Janux Therapeutics Inc (JANX)

EBITDA

-$100.69M

TTM · Period ending: · USD

JANX logo

JANX EBITDA

Latest reported-$100.69M
JANX TTM EBITDA (-$6.57M → -$100.69M)
High-resolution chart · PNG

JANX ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Janux Therapeutics Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-100,691,000
-112,499,000
-111,596,000
-99,822,000
-103,559,000
-75,695,000
-66,934,000
-58,457,000
-41,976,000
-53,560,000
-56,338,000
-60,773,000
-66,152,000
-65,895,000
-62,218,000
-59,908,000
-54,200,000
-43,613,000
-32,559,000
-20,853,000
-11,369,000
-7,526,000
-6,565,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.